Latest in News & Research

AAD Updates Guidelines for Management of Acne Vulgaris

Strong recommendations made for benzoyl peroxide, topical retinoids, topical antibiotics, oral doxycycline

By Elana Gotkine (HealthDay News) | | February 05, 2024

Gender Minority Adults Are Vulnerable During Full Body Skin Exam

Gender queer and transgender individuals more likely to report discomfort than sexual minority cisgender females, males

By Elana Gotkine (HealthDay News) | | February 02, 2024

Dapsone, Sulfasalazine Beneficial as Adjuvants in Pemphigus Vulgaris

Evidence from review supports efficacy of dapsone and sulfasalazine as adjuvant therapies

By Dermsquared Editorial Team | | January 31, 2024

Pretreatment Testing Often Omitted in Chronic Inflammatory Skin Disease

Between 11 and 59 percent of patients had tuberculosis screening within six months before treatment

By Dermsquared Editorial Team | | January 31, 2024

Early FDG PET/CT Can ID Metabolic Changes in Advanced Melanoma

Metabolic changes associated with progression-free survival in patients receiving pembrolizumab

By Elana Gotkine (HealthDay News) | | January 29, 2024

2004 to 2019 Saw Increase in Isotretinoin Use in Girls, Women

In base case analysis, 178 pregnancies were exposed to isotretinoin, with a doubling of the number per year during the study period

By Elana Gotkine (HealthDay News) | | January 25, 2024

Rituximab + Prednisone Yields Lasting Complete Remission in Pemphigus

Relapses occurred in 42.2 and 83.7 percent of patients receiving rituximab plus prednisone versus prednisone alone

By Dermsquared Editorial Team | | January 24, 2024

Most Melanomas in Black Patients Located on Acral Skin

Patients with nonacral cutaneous melanomas more likely to be immunocompromised, have personal history of cancer

By Dermsquared Editorial Team | | January 24, 2024

Climatic Hazards Linked to Aggravation of Atopic Dermatitis

Evidence of aggravation of AD seen for most climatic hazards, with impact ranging from direct to indirect effects

By Elana Gotkine (HealthDay News) | | January 24, 2024

Study IDs Risks to Offspring Associated With Prenatal Opioid Exposure

Prenatal opioid exposure linked to increased risk for infection, eczema and dermatitis, and asthma in offspring

By Elana Gotkine (HealthDay News) | | January 19, 2024

FDA Approves AI Device That Helps Spot Skin Cancer

The first medical device powered by artificial intelligence and designed to help doctors catch skin cancer has been approved by the U.S. Food and...

By Robin Foster (HealthDay News) | | January 18, 2024

Factors ID'd That Affect Medical Decision-Making in Hidradenitis Suppurativa

Five factors identified, including suffering threshold, perceptions of treatment risk, treatment fatigue

By Elana Gotkine (HealthDay News) | | January 17, 2024

What Are the Skin Cancer Recurrence Rates for Superficial X-Ray Therapy?

Over 22 years, two-, five-, and 10-year tumor recurrence rates were 2.2, 6.0, and 10.5 percent, respectively

By Dermsquared Editorial Team | | January 17, 2024

Is Dermoscopy, Reflectance Confocal Microscopy Combo Best for Assessing Vitiligo?

Sensitivity and specificity of dermoscopy combined with RCM was higher than RCM or dermoscopy alone

By Dermsquared Editorial Team | | January 17, 2024

12.8 Percent of Unique Prescribers Prescribed Topical Antifungals in 2021

Top 10 percent of prescribers by volume prescribed 44.2 percent of all prescriptions for antifungals

By Elana Gotkine (HealthDay News) | | January 11, 2024

Some Advanced Melanoma Patients Start Systemic Therapy Shortly Before Death

Reduced odds of receiving immune therapy seen in association with female sex, elevated LDH, BRAF mutation, poor ECOG performance status

By Dermsquared Editorial Team | | January 10, 2024

Does COVID-19 Infection Raise the Odds of Alopecia Areata?

Patients with COVID-19 have a significantly higher incidence of AA than controls, irrespective of clinical subtype

By Dermsquared Editorial Team | | January 10, 2024

LAUNCH ALERT: Berdazimer Topical Gel 10.3% (ZELSUVMI) Receives FDA Approval for Treatment of Molluscum Contagiosum in Adult and Pediatric Patients

The groundbreaking treatment is the first-and-only topical prescription medication for molluscum that can be applied outside of a medical setting

By Dermsquared Editorial Team | | January 08, 2024

Transgender, Gender-Diverse Individuals Report Acne-Related Stigma

Barriers to acne treatment include cost, lack of multidisciplinary care, mistrust toward health care system

By Elana Gotkine (HealthDay News) | | January 03, 2024

Does Adapalene/Benzoyl Peroxide Gel Prevent Scar Worsening in Acne?

Maintenance therapy with adapalene/benzoyl peroxide gel and benzoyl peroxide gel effective in acne vulgaris

By Dermsquared Editorial Team | | January 03, 2024

Variants in Cancer-Predisposing Genes Linked to Early-Onset Merkel Cell Carcinoma

19 percent of patients with early-onset Merkel cell carcinoma have well-described variants in genes associated with cancer predisposition

By Dermsquared Editorial Team | | January 03, 2024

Skin Clinic Visits Increased With High Carbon Monoxide Levels Due to Wildfires

Atypical summer peak CO levels in Boston region in 2023 linked to spike in AD, dermatitis, eczema-related clinic visits

By Elana Gotkine (HealthDay News) | | January 03, 2024

Biological Agent Trials for Psoriasis Rarely Include Patient Images

A total of 203 images were shared depicting 60 patients, for an overall sharing rate of 0.1 percent

By Elana Gotkine (HealthDay News) | | December 29, 2023

24 of 1274

Headline from the Week of August 17 - 23, 2026

Peripheral Globules, Related Lesion Dynamics Predict Outcomes in Melanocytic Nevi

By Dermsquared Editorial Team | | August 18, 2026

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

By Dermsquared Editorial Team | | August 18, 2026